TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
1. TransCode announces 1-for-33 reverse stock split approved by shareholders. 2. The reverse split aims to boost share price for Nasdaq compliance. 3. Outstanding shares will reduce from 17 million to approximately 696,000. 4. Adjustments will be made to stock options and incentive plans. 5. New CUSIP number will be effective following the reverse stock split.